A review of the off-label use of selamectin (Stronghold/Revolution) in dogs and cats
- PMID: 19032763
- PMCID: PMC2612660
- DOI: 10.1186/1751-0147-50-46
A review of the off-label use of selamectin (Stronghold/Revolution) in dogs and cats
Abstract
Since its introduction approximately seven years ago, selamectin (Stronghold/Revolution, Pfizer Inc.) has been used off-label to treat a number of ecto- and endoparasite conditions in dogs and cats. It has been used as a successful prophylactic against Dirofilaria repens and as a treatment for Aelurostrongylus abstrusus in cats. It has also been used to treat notoedric mange, infestation with the nasal mite Pneumonyssoides caninum, Cheyletiella spp. and Neotrombicula autumnalis infestations and larval Cordylobia anthropophaga infection. However, to date attempts to treat generalised canine demodicosis have not been successful. In all cases, treatment was apparently well tolerated by the host.
References
-
- Blagburn BL. Proceedings of the Fourth World Congress of Veterinary Dermatology: 30th August to 2nd September 2000; San Francisco. Blackwell Science; 2002. Changing trends in ectoparasite control.
-
- Campbell WC. Ivermectin and Abamectin. Springer, New York; 1989.
-
- Pulliam JD, Seward RL, Henry RT. Investigating ivermectin toxicity in collies. Vet Med. 1985;80:33–40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
